Dr. Michael D.
Diamantidis
Thalassemia
Unit, General Hospital of Larisa, Greece
Email:
diamantidis76@gmail.com
Qualifications
2014-today
Consultant Haematologist, Thalassemia Unit, General Hospital of Larisa, Greece
2013-2014
Post-Doc, Department of Haematology, Erasmus MC, Rotterdam, the Netherlands
2007-2011
Ph.D., Medical School, Aristotle University of Thessaloniki, Greece
2005-2011
Specialization in haematology, Greece
2004-2006
M.Sc., Medical School, Aristotle University of Thessaloniki, Greece
1995-2001
M.D., Faculty of Medicine, Aristotle University of Thessaloniki, Greece
Publications
(Selected)
-
Diamantidis
MD, Ioannidou – Papagiannaki E, Kountouras J, Mandala E, Klonizakis P, Frida –
Michailidou I, Tsapournas G, Haralambidou – Vranitsa S, Klonizakis I.
Helicobacter Pyloriinfection might protect from the leukaemic transformation of
myelodysplastic syndromes. Med Hypotheses 2008; 71(1):159-160.
-
Diamantidis
M, Tsapournas G, Kountouras J, Zavos C. New aspects of regulatory signaling
pathways and novel therapies in pancreatic cancer. Curr Mol Med 2008;
8(1):12-37.
-
Papadopoulos
A, Ntaios G, Kaiafa G, Girtovitis F, Saouli Z, Kontoninas Z, Diamantidis MD,
Savopoulos C, Hatzitolios A. Veno-occlusive disease of the liver during
induction therapy for acute lymphoblastic leukemia. Int J Hematol 2008; 88(4):441-442.
-
Papadopoulos
A, Ntaios G, Kaiafa G, Girtovitis F, Saouli Z, Kontoninas Z, Diamantidis MD,
Savopoulos C, Hatzitolios A. Increased incidence of iron deficiency anemia
secondary to inadequate iron intake in institutionalized, young patients with
cerebral palsy. Int J Hematol 2008; 88(5):495-497.
-
Kountouras
J, Zavos C, Diamantidis MD, Deretzi G, Grigoriadis N, Tsapournas G, Katsinelos
P, Molyvas E. A concept of Helicobacter pylori and stress-secreted mast cells
potential involvement in brain metastases. J Neuroimmunol 2009;
209(1-2):121-122.
-
Diamantidis
MD, Ioannidou-Papagiannaki E, Ntaios G. Novel extended reference range for
serum κ/λ free light chain ratio in diagnosing monoclonal gammopathies in renal
insufficient patients. Clin Biochem 2009; 42(10-11):1202-1203.
-
Diamantidis
MD, Papadopoulos A, Kaiafa G, Ntaios G, Karayannopoulou G, Kostopoulos I,
Girtovitis F, Saouli Z, Kontoninas Z, Raptis ID, Savopoulos C, Hatzitolios A.
Differential diagnosis and treatment of primary, cutaneous, anaplastic large
cell lymphoma: not always an easy task. Int J Hematol 2009; 90(2):226-229.
-
Ifantidou
AM, Diamantidis MD, Tseliki G, Angelou AS, Christidou P, Papa A, Pentilas D.
Corynebacterium jeikeium bacteremia in a hemodialyzed patient. Int J Infect Dis
2010; 14S3:e265-e268.
-
Diamantidis
MD, Ioannidou-Papagiannaki E, Kountouras J, Mandala E, Tsapournas G,
Frida-Michailidou I, Klonizakis P, Zavos C, Haralambidou-Vranitsa S, Vlachaki
E, Parapanisiou E, Klonizakis I. High prevalence of Helicobacter pylori
infection in Greek patients with myelodysplastic syndromes. Acta Haematol 2010;
124(3):141-149.
-
Diamantidis
MD, Myrou AD, Kaiafa GD, Kaloutsi V, Karayannopoulou G, Theodoridis A, Adamidou
A, Papadopoulos A, Grekas D. Aggressive systemic mastocytosis associated with
mesangioproliferative glomerulonephritis. Acta Haematol 2011; 125(3):153-159.
The figures of the publication were chosen to form the cover of the issue of
the Journal.
-
Giouleme
O, Diamantidis MD, Katsaros MG. Is diabetes a causal agent for colorectal
cancer? Pathophysiological and molecular mechanisms. World J Gastroenterol
2011; 17(4):444-448.
-
Zavos
C, Kountouras J, Katsinelos P, Polyzos SA, Deretzi G, Zavos N, Fragaki M,
Diamantidis MD. Modern industrialisation may increase primary open-angle
glaucoma through easier transmission of Helicobacter pylori infection. Med
Hypotheses 2011; 76(5):766-767.
-
Diamantidis
MD, Myrou AD. Perils and pitfalls regarding differential diagnosis and
treatment of primary cutaneous anaplastic large-cell lymphoma. Invited Review
by Professor Edward J. Benz, Jr. TheScientificWorldJournal 2011; 11:1048-1055.
-
Kaiafa
GD, Perifanis V, Diamantidis MD, Giouleme O, Voulgaridou V, Beretouli E,
Kalogera-Fountzila A, Kaloutsi V. Aberrant expression of myeloid and B cell
markers in an aggressive multiple-site myeloid sarcoma. Ann Hematol 2012;
91(7):1157-1159.
-
Diamantidis
MD. Ruxolitinib for myelofibrosis. N Engl J Med 2012; 366(21): 2031.
-
Kaiafa
GD, Saouli Z, Diamantidis MD, Kontoninas Z, Voulgaridou V, Raptaki M, Arampatzi
S, Chatzidimitriou M, Perifanis V. Copper levels in patients with
haematological malignancies. Eur J Intern Med 2012; 23(8):738-741.
-
Kaiafa
G, Chalvatzi K, Diamantidis MD, Voulgaridou V, Kostopoulos I,
Kalogera-Fountzila A, Koletsa T, Bougatsa V, Archonti A, Perifanis V. Acute
vision loss revealing central nervous system aggressive myelomatosis. J Neurol
2012; 259(12):2749-2751.
-
Diamantidis
MD, Kostopoulos I, Kaiafa G. Alpha heavy chain disease: a rare lymphoma hard to
diagnose. Hippokratia 2014; 18(1):95.
-
Hatjiharissi
E, Diamantidis MD, Papaioannou M, Dimou T, Chrisoulidou A, Patakiouta F,
Constantinou N, Pazaitou-Panayiotou K. Long-term outcome of primary endocrine
non-Hodgkin lymphomas: Does the site make the difference? QJM 2013;
106(7):623-630.
-
Papagiannakis
P, Michalopoulos C, Papalexi F, Dalampoura D, Diamantidis MD. The role of
Helicobacter pylori infection in hematological disorders. Eur J Intern Med
2013; 24(8):685-690.
-
Diamantidis
MD, Papagiannakis P, Papalexi F,Michalopoulos C, Stavrou G. Supplementary
information regarding Helicobacter pylori, concomitant infections,
lymphomagenesis and cardiovascular disease. Eur J Intern Med 2013;
25(1):e9-e10.
-
Arampatzi
S, Diamantidis MD, Perifanis V, Diza E, Kaiafa G. Successful treatment with
Rituximab in a patient with life-threatening resistant Thrombotic Thrombopenic
Purpura. Hippokratia 2012; 16(4):388.
-
Perifanis
V, Diamantidis MD, Chalvatzi K, Kaloutsi V, Markala D, Voulgaridou V,
Pantelidou P, Pavlidis A, Stavrou G, Kaiafa G. Concurrent presentation of nodal
myeloid sarcoma and bone marrow chronic lymphocytic leukemia/small lymphocytic
lymphoma: a unique association. Int J Hematol 2014; 99(4): 508-512.
-
Diamantidis
MD, Papaioannou M. Toward adjunctive therapy of acute myeloid leukemia: Is it
feasible?